Ferroptosis and its implications in bone-related diseases

Area of Science:

• Biomedical Science
• Cell Biology
• Orthopedics

Background:

• Ferroptosis, a regulated cell death (RCD) pathway driven by iron-dependent lipid peroxidation, is increasingly implicated in bone pathologies.
• Bone diseases such as osteoporosis (OP), osteoarthritis (OA), and osteosarcoma (OS) significantly impact public health, particularly in aging and adolescent populations.

Purpose of the Study:

• To review the characteristics and mechanisms of ferroptosis.
• To elucidate the role of ferroptosis in OP, OA, and OS.
• To summarize factors modulating ferroptosis in bone diseases for therapeutic insights.

Main Methods:

• Literature review of ferroptosis mechanisms.
• Analysis of ferroptosis involvement in OP, OA, and OS pathogenesis.
• Compilation of chemical and biological regulators of ferroptosis in bone.

Main Results:

• Ferroptosis is a critical regulator in the pathogenesis of osteoporosis, osteoarthritis, and osteosarcoma.
• Specific chemical compounds and biological factors have been identified that modulate ferroptosis in the context of bone diseases.
• Current research highlights ferroptosis as a potential therapeutic target for bone-related conditions.

Conclusions:

• Ferroptosis is a significant factor in bone diseases, offering novel therapeutic avenues.
• Targeting ferroptosis presents a promising strategy for managing osteoporosis, osteoarthritis, and osteosarcoma.
• Further research into ferroptosis regulation can lead to effective treatments for bone pathologies.